Study of KIR expression and HLA ligands in CD56+ lymphocytes of drug resistant tuberculosis patients.

doi:010.03/ijaai.189194

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Study of KIR expression and HLA ligands in CD56+ lymphocytes of drug resistant tuberculosis patients.

Iranian journal of allergy, asthma, and immunology - 1 Sept 2011

Mousavi Tahereh, Shahsavar Farhad, Farnia Parisa, Tajik Nader, Soofi Mahbubeh

Abstract excerpt

Analysis of receptor-ligand interactions in the context of diseases necessitates to understand how HLA-KIR genotypes function in diseases. Although CD56+ lymphocytes are derived from multiple lineages, they share a functional association with immunosurviellance and antimicrobial responses. The present study aimed to determine whether KIR phenotype in CD56 lymphocytes and corresponding HLA-class 1 ligands are...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CD56 Antigen
Share to Flow Cytometry
Share to HLA Antigens
Share to Killer Cells, Natural

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ligands

Share to Natural Killer T-Cells

Share to Receptors, KIR

Share to Tuberculosis, Multidrug-Resistant

Source

Open in PubMed

Identifiers

PMID: 21891825
DOI: 010.03/ijaai.189194

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 5 Sept 2026. Manifest publication-graph-cohort-2026-09-05.1.

Source receipt: pubmed, retrieved 5 Sept 2026.